NCT00543608View on ClinicalTrials.gov

Clinical Efficacy of Intravenous Iclaprim Versus Vancomycin in the Treatment of Hospital-Acquired, Ventilator-Associated, or Health-Care-Associated Pneumonia

PHASE2TerminatedINTERVENTIONAL
Enrollment

135

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

April 30, 2009

Study Completion Date

May 31, 2009

Conditions
Hospital-Acquired PneumoniaVentilator-Associated PneumoniaHealth-Care-Associated Pneumonia
Interventions
DRUG

iclaprim

DRUG

vancomycin

Sponsors

Lead Sponsor

Arpida AG
All Listed Sponsors
lead

Arpida AG

INDUSTRY

NCT00543608 - Clinical Efficacy of Intravenous Iclaprim Versus Vancomycin in the Treatment of Hospital-Acquired, Ventilator-Associated, or Health-Care-Associated Pneumonia | Biotech Hunter | Biotech Hunter